טוען...
Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable
This article affects the problems of using NOAC in the most defenseless groups of patients with atrial fibrillation: those who have high bleeding and high thromboembolic risk and elderly. The focus is on comparison of effectiveness and safety of NOACs based on randomized clinical trials (RCT) an...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Stolichnaya Izdatelskaya Kompaniya
2018-11-01
|
| סדרה: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| נושאים: | |
| גישה מקוונת: | https://www.rpcardio.com/jour/article/view/1769 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|